TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8393606

Group type: EXPERIMENTAL
Intervention: 10(4) p.f.u. dose of rhesus rotavirus serotype 3
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: 10(5) p.f.u. dose of rhesus rotavirus serotype 3
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: 10(4) p.f.u. dose of tetravalent rotavirus vaccine
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: 10(5) p.f.u. dose of tetravalent rotavirus vaccine
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Grouped vaccines at 10(5) p.f.u. (single serotype and tetravalent)
Number of subjects: 213
Study: 3578925

Group type: EXPERIMENTAL
Intervention: Intranasal IgE pentapeptide 0.5%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30594314

Group type: EXPERIMENTAL
Intervention: firefighters' worn
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: snogg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: flexible tarp
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: strap
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: inflated stretcher
Number of subjects: 160
Study: 27619403

Group type: EXPERIMENTAL
Intervention: 1000 mg omega-3 fatty acids from flaxseed oil containing 400 mg α-Linolenic acid plus 400 IU vitamin E supplements (n = 34)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 1000 mg omega-3 fatty acids and vitamin E co-supplementation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (n = 34)
Number of subjects: 68
Study: 25739424

Group type: EXPERIMENTAL
Intervention: Recommendations for the prevention of hand eczema
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Knowledge about the recommendations
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Testing products beforehand and collaboration with infection control department
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Fit of recommendations with healthcare workers' work
Number of subjects: 19
Study: 23511706

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Diet + LIRET
Number of subjects: 41

Group type: COMPARATOR
Intervention: LIRET
Number of subjects: 41
Study: 21718992

Group type: EXPERIMENTAL
Intervention: OCP (0.030 ethinyl E(2)/0.15 desogestrel) for 12‐16 days
Number of subjects: 228

Group type: COMPARATOR
Intervention: Long protocol from day 20‐22 of the previous cycle
Number of subjects: 228
Study: 19196862

Group type: EXPERIMENTAL
Intervention: Removal of low nutrition snacks and beverages from three middle schools
Number of subjects: 6

Group type: COMPARATOR
Intervention: No systematic changes in three comparison schools
Number of subjects: 6
Study: 17264186

Group type: EXPERIMENTAL
Intervention: Growth hormone treatment (1 mg/m2.d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-GH treated control group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Growth hormone treatment
Number of subjects: 20
Study: 14749230

Group type: EXPERIMENTAL
Intervention: NaFeEDTA-containing food product
Number of subjects: 13

Group type: COMPARATOR
Intervention: Ferrous sulfate-containing food product
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Higher dietary calcium
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard food product with calcium
Number of subjects: 13
Study: 11325685

Group type: EXPERIMENTAL
Intervention: Intravenous L-carnitine, 20 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intravenous L-carnitine, 10 mg/kg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intravenous L-carnitine, 40 mg/kg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intravenous L-carnitine
Number of subjects: 28
Study: 9621293

Group type: EXPERIMENTAL
Intervention: Mupirocin ointment applied at the cannula site after catheter placement and at the end of each dialysis session
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Mupirocin ointment
Number of subjects: 136
Study: 7772106

Group type: EXPERIMENTAL
Intervention: Hysteroscopic surgery (transcervical resection and laser ablation)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Hysteroscopic surgery
Number of subjects: 204

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 204
Study: 3310506

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate 1% (Healon)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Methylcellulose 2%
Number of subjects: 30
Study: 2363109

Group type: EXPERIMENTAL
Intervention: Lidocaine (20 mg/ml) with epinephrine (12.5 micrograms/ml)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Prilocaine (30 mg/ml) with felypressin (0.54 microgram/ml)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mepivacaine (30 mg/ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 40
Study: 1244844

Group type: EXPERIMENTAL
Intervention: Increasing dietary protein content
Number of subjects: 11

Group type: COMPARATOR
Intervention: Normal dietary protein content
Number of subjects: 11
Study: 30893162

Group type: EXPERIMENTAL
Intervention: 20-U prabotulinumtoxinA
Number of subjects: 654

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 654
Study: 28923788

Group type: EXPERIMENTAL
Intervention: Interactive video game intervention (up to 16 hours over 6 weeks)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Interactive video game intervention
Number of subjects: 333

Group type: COMPARATOR
Intervention: Control video games
Number of subjects: 333
Study: 26183690

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (ladder climbing with tail weight, 3 days/week for 12 weeks)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Elastic band exercise program (12 weeks, 1-hour session, 2 days/week)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2
Study: 23220355

Group type: EXPERIMENTAL
Intervention: Menu with calorie information and miles to walk to burn those calories
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Menu with calorie information and minutes to walk to burn those calories
Number of subjects: 802

Group type: EXPERIMENTAL
Intervention: Menu with calorie information
Number of subjects: 802

Group type: COMPARATOR
Intervention: Menu with no nutritional information
Number of subjects: 802
Study: 21508826

Group type: EXPERIMENTAL
Intervention: S-ketamine 20 mg/70 kg/h with rifampicin (600 mg once daily for 5 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: S-ketamine 40 mg/70 kg/h with rifampicin (600 mg once daily for 5 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: S-ketamine with rifampicin
Number of subjects: 20
Study: 19330495

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 301

Group type: COMPARATOR
Intervention: Current standard of care
Number of subjects: 301
Study: 16773290

Group type: EXPERIMENTAL
Intervention: Lactulose
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fibre
Number of subjects: 50
Study: 15593207

Group type: EXPERIMENTAL
Intervention: Low-dose intravenous cyclophosphamide (IV CYC) regimen (6 pulses of 500 mg given at intervals of 2 weeks) followed by azathioprine (AZA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: High-dose intravenous cyclophosphamide (IV CYC) regimen (6 monthly pulses and 2 quarterly pulses with escalating doses) followed by azathioprine (AZA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Early response to therapy (defined as a decrease in serum creatinine level and proteinuria <1 g/24 hours)
Number of subjects: 90
Study: 11287243

Group type: EXPERIMENTAL
Intervention: Intervention group (brief alcohol abuse prevention program)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1000
Study: 9262814

Group type: EXPERIMENTAL
Intervention: Arm arterial occlusion cuffs (AAOC)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No intervention (without AAOC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Arm arterial occlusion cuffs (AAOC) during complex profile
Number of subjects: 6
Study: 8333773

Group type: EXPERIMENTAL
Intervention: Intermittent growth hormone treatment (three weeks of every four)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous growth hormone treatment (daily injection)
Number of subjects: 0
Study: 3714912

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline (placebo) infusion
Number of subjects: 20
Study: 29701615

Group type: EXPERIMENTAL
Intervention: Self-reported inattentive ADHD T-scores
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Self-reported hyperactive-impulsive ADHD T-scores
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Self-reported conduct disorder T-scores
Number of subjects: 60

Group type: COMPARATOR
Intervention: Parent report measures
Number of subjects: 60
Study: 28851412

Group type: EXPERIMENTAL
Intervention: Structured program aimed at improving motor skills
Number of subjects: 368

Group type: COMPARATOR
Intervention: Control group (no intervention for the first three years)
Number of subjects: 368
Study: 26225500

Group type: EXPERIMENTAL
Intervention: QLB with 0.125% bupivacaine 0.2 ml kg⁻¹ (Group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (QLB with 0.9% Normal saline 0.2 ml kg⁻¹)
Number of subjects: 50
Study: 24190233

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (EPA 1245 mg/day, DHA 540 mg/day)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (no EPA or DHA)
Number of subjects: 27
Study: 21361734

Group type: EXPERIMENTAL
Intervention: Testosterone application after showering (standard regimen)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Shower taken 30 minutes after testosterone application
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Shower taken 15 minutes after testosterone application
Number of subjects: 10
Study: 18940887

Group type: EXPERIMENTAL
Intervention: HDB tirofiban
Number of subjects: 692

Group type: COMPARATOR
Intervention: abciximab
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: HDB tirofiban vs abciximab
Number of subjects: 692

Group type: EXPERIMENTAL
Intervention: HDB tirofiban and abciximab
Number of subjects: 692
Study: 18706028

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN, 5 mg/day)
Number of subjects: 5000

Group type: COMPARATOR
Intervention: No GTN (control)
Number of subjects: 5000
Study: 12166558

Group type: EXPERIMENTAL
Intervention: Interval Training (IT) - work for 30 s at 100% of peak work-rate alternating with 30-s rest intervals, cycling 40 min x day(‐1) and 2 days x week(‐1) for 12 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Continuous Training (CT) - exercise at 50% of baseline peak work-rate, cycling 40 min x day(‐1) and 2 days x week(‐1) for 12 weeks
Number of subjects: 36
Study: 9682028

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (PIP/TAZ)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cefepime (CEFP)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both PIP/TAZ and CEFP
Number of subjects: 100
Study: 8576671

Group type: EXPERIMENTAL
Intervention: Intravenous PCA (Patient-Controlled Analgesia)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional method (Intramuscular q.i.d. injection and p.r.n. injection)
Number of subjects: 0
Study: 2354091

Group type: EXPERIMENTAL
Intervention: 3 ml of plain 0.5% bupivacaine injected at L3-4
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 ml of plain 0.5% bupivacaine injected at L4-5
Number of subjects: 80
Study: 509055

Group type: EXPERIMENTAL
Intervention: Adjuvant umbilical vein cytotoxic perfusion with 5-fluorouracil
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (no perfusion)
Number of subjects: 154
Study: 31340046

Group type: EXPERIMENTAL
Intervention: Routine monitoring for hypoglycemia
Number of subjects: 196
Study: 29171020

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg on day 1 and 75 mg on day 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg on day 1 and 10 mg on day 2)
Number of subjects: 0
Study: 26861924

Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 1441
Study: 25197999

Group type: EXPERIMENTAL
Intervention: Verbal and visual education
Number of subjects: 54

Group type: COMPARATOR
Intervention: Verbal education
Number of subjects: 54
Study: 22721455

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (triamcinolone acetonide)
Number of subjects: 100

Group type: COMPARATOR
Intervention: NSAID injection (diclofenac sodium)
Number of subjects: 100
Study: 19672733

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - oral 0.625 mg conjugated estrogen + 2.5 mg medroxyprogesterone acetate/day for 3 and 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no HRT)
Number of subjects: 60
Study: 17377770

Group type: EXPERIMENTAL
Intervention: Intravenous fish oil fat emulsion (0.5 g/kg 10% emulsion, Omegaven) administered twice, 48 and 24 hours before investigation.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no treatment).
Number of subjects: 16
Study: 16276692

Group type: EXPERIMENTAL
Intervention: Budesonide 400 microg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate 400 microg twice daily
Number of subjects: 0
Study: 12042011

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug therapy (amiodarone, propafenone, flecainide, sotalol)
Number of subjects: 68

Group type: COMPARATOR
Intervention: No antiarrhythmic drug therapy
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug therapy
Number of subjects: 68
Study: 10213329

Group type: EXPERIMENTAL
Intervention: Propiverine 15 mg t.i.d.
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo t.i.d.
Number of subjects: 113
Study: 7606516

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium, 4 mg aerosol 30 min before challenge
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 2206227

Group type: EXPERIMENTAL
Intervention: Triple drug treatment (azathioprine, cyclosporin, methylprednisolone)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Aza and MP (group A)
Number of subjects: 128

Group type: COMPARATOR
Intervention: CyA monotherapy (group B)
Number of subjects: 128

Group type: COMPARATOR
Intervention: CyA and MP (group C)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Triple drug treatment
Number of subjects: 128

Group type: COMPARATOR
Intervention: Aza and MP, CyA monotherapy, CyA and MP (controls)
Number of subjects: 128
Study: 400933

Group type: EXPERIMENTAL
Intervention: Cefoxitin (2.0 g intramuscularly with 1.0 g of oral probenecid)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Aqueous procaine penicillin G (4.8 x 10(6) units intramuscularly with 1.0 g of oral probenecid)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 143
Study: 31256715

Group type: EXPERIMENTAL
Intervention: Various lifejacket designs trialed with lobstermen, nine designs were tested during winter and summer fishing seasons.
Number of subjects: 181
Study: 29095006

Group type: EXPERIMENTAL
Intervention: Moderate physical activity program in the aquatic environment (SWEP method)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sedentary women (Control group)
Number of subjects: 140
Study: 26494629

Group type: EXPERIMENTAL
Intervention: Pentax AWS
Number of subjects: 67

Group type: COMPARATOR
Intervention: Airtraq
Number of subjects: 67

Group type: COMPARATOR
Intervention: McCoy
Number of subjects: 67
Study: 24309749

Group type: EXPERIMENTAL
Intervention: Multisensory stimulation (audiotactile)
Number of subjects: 36
Study: 23048052

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 3798

Group type: COMPARATOR
Intervention: Heparin plus GPI
Number of subjects: 3798
Study: 19741492

Group type: EXPERIMENTAL
Intervention: Early epidural (cervical dilation at least 1.0 cm)
Number of subjects: 12793

Group type: COMPARATOR
Intervention: Delayed epidural (cervical dilation at least 4.0 cm)
Number of subjects: 12793
Study: 17889772

Group type: EXPERIMENTAL
Intervention: ACR6D SE IOL (angulated)
Number of subjects: 44

Group type: COMPARATOR
Intervention: C‐flex 570C IOL (nonangulated)
Number of subjects: 44
Study: 15200541

Group type: EXPERIMENTAL
Intervention: Bupivacaine irrigation through the axillary wound drain 4-hourly for 24 h postoperatively
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline irrigation through the axillary wound drain
Number of subjects: 100
Study: 12047399

Group type: EXPERIMENTAL
Intervention: glyburide/metformin 1.25/250 mg
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: glyburide/metformin 2.5/500 mg
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: glyburide/metformin (both doses)
Number of subjects: 806
Study: 9524979

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2059756

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX 10 mg/m2) given on days 1, 3, and 6, and daily cyclosporine (CSP) on days -1 through 180
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Conditioning regimen with mild toxicity
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Conditioning regimen with moderate toxicity
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Conditioning regimen with severe toxicity
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Three doses of MTX and daily CSP
Number of subjects: 34
Study: 6841304

Group type: EXPERIMENTAL
Intervention: Acyclovir, 10 and 15 mg/kg 8 hourly, given as an iv bolus or iv infusion over 1 h for up to 7 days
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acyclovir, 10 and 15 mg/kg 8 hourly, given as an iv bolus
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acyclovir, high dosage by iv bolus mode of administration
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acyclovir, 15 mg/kg 8‐hourly
Number of subjects: 6
Study: 29931570

Group type: EXPERIMENTAL
Intervention: Optical low-coherence reflectometry (OLCR) biometry
Number of subjects: 102
Study: 30058646

Group type: EXPERIMENTAL
Intervention: Oral CoQ10 supplementation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Precooling strategy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Supplementation with precooling
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 26177791

Group type: EXPERIMENTAL
Intervention: Alendronate (ALN) 70 mg weekly for 48 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Alendronate (ALN)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Baseline 25(OH)D < 32 ng/mL
Number of subjects: 82
Study: 25153957

Group type: EXPERIMENTAL
Intervention: Han participants
Number of subjects: 128

Group type: COMPARATOR
Intervention: Tibetan participants
Number of subjects: 128
Study: 23342876

Group type: EXPERIMENTAL
Intervention: Strategy 1: 1 of 3 criteria (inflammatory back pain, HLA‐B27, sacroiliitis on imaging)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Strategy 2: 2 of 6 criteria (IBP inflammatory back pain, HLA‐B27, sacroiliitis, family history, good response to NSAIDs, extra‐articular manifestations)
Number of subjects: 141
Study: 20150883

Group type: EXPERIMENTAL
Intervention: 1 Hz real-rTMS of the SI cortex for 30 minutes daily for 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham-rTMS
Number of subjects: 20
Study: 18277063

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Low-intensity exercise
Number of subjects: 36

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 36
Study: 16188715

Group type: EXPERIMENTAL
Intervention: Psychotherapy (eight sessions of cognitive behavioral therapy) plus pharmacotherapy (citalopram)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Assessment only condition
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 109
Study: 12885836

Group type: EXPERIMENTAL
Intervention: Standard timing chemotherapy (DCTER: dexamethasone, cytarabine arabinoside, 6‐thioguanine, etoposide, daunorubicin)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Standard timing chemotherapy (DCTER)
Number of subjects: 161
Study: 10883766

Group type: EXPERIMENTAL
Intervention: Tone of voice
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Verbal content
Number of subjects: 182
Study: 9322463

Group type: EXPERIMENTAL
Intervention: Sufentanil 10 micrograms plus dextrose 7.5%
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sufentanil 10 micrograms plus saline
Number of subjects: 66

Group type: COMPARATOR
Intervention: Plain dextrose 7.5%
Number of subjects: 66
Study: 8458774

Group type: EXPERIMENTAL
Intervention: Naloxone (3 mg intravenous infusion)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study: 2429117

Group type: EXPERIMENTAL
Intervention: Clonidine (200 micrograms as a single dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chronic administration of clonidine (200 micrograms twice a day for 3 weeks)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chronic administration of clonidine (400 micrograms twice a day for 6 weeks)
Number of subjects: 12
Study: 30439315

Group type: EXPERIMENTAL
Intervention: Comfort analgesic sedative scheme with immediate analgesia and sedation score, CPOT 0-1 and RASS -1-0.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Daily analgesic and sedation regimen with CPOT 0-3 and RASS maintained at -3 to -4.
Number of subjects: 80
Study: 26428903

Group type: EXPERIMENTAL
Intervention: High-Velocity (HV) quadriceps exercises
Number of subjects: 21

Group type: COMPARATOR
Intervention: Slow-Velocity (SV) quadriceps exercises
Number of subjects: 21
Study: 24856942

Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance foot and ankle exercise programme (HIGH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-intensity foot and ankle exercise control programme (LOW)
Number of subjects: 60
Study: 22548261

Group type: EXPERIMENTAL
Intervention: Research network support
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: CSOs involvement
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Research network contribution
Number of subjects: 9
Study: 19945740

Group type: EXPERIMENTAL
Intervention: Six cycles of chemotherapy
Number of subjects: 427

Group type: COMPARATOR
Intervention: Three cycles of chemotherapy
Number of subjects: 427